Joseph M. ConnorsMD, FRCP
Dr Connors received his MD from Yale University and did his Internal Medicine residency training and chief residency at the University of North Carolina in Chapel Hill. . He then worked in the Indian Health Service in Alaska for two years before completing his Medical Oncology Fellowship at Stanford University under Dr Saul Rosenberg. He accepted a position in Medical Oncology at the BC Cancer Agency in 1981 and has been a member of the Faculty of Medicine at the University of British Columbia since that time reaching the position of Clinical Professor in 1997. Presently he is a Clinical Professor in the Department of Medicine, Division of Medical Oncology, at the University of British Columbia and the chair of the Lymphoma Tumor Group for the British Columbia Cancer Agency and focuses his clinical activities and research efforts in the area of understanding lymphoid cancers.
Dr. Connors is best known for his clinical investigations into the treatment of Hodgkin lymphoma, non-Hodgkin lymphoma, chronic lymphocytic leukemias and multiple myeloma. He serves as a member of the executive committee of the Hematology Site Group for the National Cancer Institute of Canada Clinical Trials Group, as chair of the Educational Activities Committee of the American Society of Hematology and on the scientific advisory boards of the Lymphoma Foundation Canada and the Lymphoma Research Foundation of the United States.
Dr. Connors has published over 250 peer-reviewed scientific articles addressing various aspects of research into lymphoid cancers. He has been awarded the Terry Fox Cancer Research Award by the British Columbia Medical Association, the Bernard L. Schwartz Memorial Award by the Scripps health system in San Diego, California, the Canadian Cancer Society John W. Whittick Memorial Award by the Saskatchewan Medical Association and the Karl Musshoff Award of the German Hodgkin Lymphoma Study Group, Cologne, Germany.